CN1139580C - 取代的苄胺及它们用于治疗抑郁症的用途 - Google Patents

取代的苄胺及它们用于治疗抑郁症的用途 Download PDF

Info

Publication number
CN1139580C
CN1139580C CNB971947376A CN97194737A CN1139580C CN 1139580 C CN1139580 C CN 1139580C CN B971947376 A CNB971947376 A CN B971947376A CN 97194737 A CN97194737 A CN 97194737A CN 1139580 C CN1139580 C CN 1139580C
Authority
CN
China
Prior art keywords
alkyl
radical
benzisoxazol
aryl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB971947376A
Other languages
English (en)
Chinese (zh)
Other versions
CN1219169A (zh
Inventor
D��C��M����ɭ
D·C·M·雷森
F��·��
G·S·F·路特
M���ֵ�˹
J·T·M·林德斯
F·A·迪杰克斯
A
S·J·A·格罗威
D·R·雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of CN1219169A publication Critical patent/CN1219169A/zh
Application granted granted Critical
Publication of CN1139580C publication Critical patent/CN1139580C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
CNB971947376A 1996-04-19 1997-04-15 取代的苄胺及它们用于治疗抑郁症的用途 Expired - Lifetime CN1139580C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201065.8 1996-04-19
EP96201065 1996-04-19

Publications (2)

Publication Number Publication Date
CN1219169A CN1219169A (zh) 1999-06-09
CN1139580C true CN1139580C (zh) 2004-02-25

Family

ID=8223896

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB971947376A Expired - Lifetime CN1139580C (zh) 1996-04-19 1997-04-15 取代的苄胺及它们用于治疗抑郁症的用途

Country Status (24)

Country Link
EP (1) EP0898566B1 (enExample)
JP (1) JP4008033B2 (enExample)
CN (1) CN1139580C (enExample)
AR (1) AR006719A1 (enExample)
AT (1) ATE227278T1 (enExample)
AU (1) AU725847B2 (enExample)
BR (1) BR9708790A (enExample)
CA (1) CA2251820C (enExample)
CZ (1) CZ295747B6 (enExample)
DE (1) DE69716896T2 (enExample)
DK (1) DK0898566T3 (enExample)
ES (1) ES2186888T3 (enExample)
HU (1) HU224637B1 (enExample)
ID (1) ID17723A (enExample)
IL (1) IL120669A (enExample)
NO (1) NO311976B1 (enExample)
NZ (1) NZ332334A (enExample)
PL (1) PL192561B1 (enExample)
PT (1) PT898566E (enExample)
RU (1) RU2179553C2 (enExample)
TR (1) TR199802104T2 (enExample)
TW (1) TW498070B (enExample)
WO (1) WO1997040027A1 (enExample)
ZA (1) ZA973209B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080773A (en) 1997-10-14 2000-06-27 Akzo Nobel, N.V. Benzylamine derivatives which are useful in treating psychiatric disorders
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
IL148622A0 (en) * 1999-09-14 2002-09-12 Aventis Pharm Prod Inc Benzisoxazolyl-pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as d4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
ATE421505T1 (de) * 2002-07-19 2009-02-15 Memory Pharmaceutical Corp 4-aminobenzofuranverbindungen als phosphodiesterase-4-inhibitoren
KR100742014B1 (ko) * 2003-08-14 2007-07-23 에프. 호프만-라 로슈 아게 Ｇａｂａ계 조절제
GB0321538D0 (en) 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
JP5432526B2 (ja) * 2006-01-06 2014-03-05 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害剤としてのシクロアルキルアミン
EP1925305A1 (en) * 2006-10-23 2008-05-28 N.V. Organon Ih channel inhibitors for the promotion of wakefulness
SA109310013B1 (ar) 2008-12-24 2013-07-28 Astrazeneca Ab مركبات إيثان أمين وطرق لتحضيرها
EP2473489B1 (en) 2009-07-07 2013-08-21 Merck Sharp & Dohme B.V. 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives
CN102942464B (zh) * 2012-12-06 2015-04-08 西北师范大学 化合物1-(2-卤苯基)-3-甲基-丁酮-1的合成方法
CN112300061B (zh) * 2020-10-06 2022-02-18 大连理工大学 一种含氮杂环二芳酮化合物的制备方法
GB202103008D0 (en) 2021-03-03 2021-04-14 King S College London Compounds
GB202103012D0 (en) 2021-03-03 2021-04-14 King S College London Compounds
GB202103017D0 (en) 2021-03-03 2021-04-14 King S College London Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980365A (en) * 1987-07-13 1990-12-25 Hoechst-Roussel Pharmaceuticals Inc. N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DE69716896T2 (de) 2003-07-24
DE69716896D1 (de) 2002-12-12
JP4008033B2 (ja) 2007-11-14
AU2387097A (en) 1997-11-12
ZA973209B (en) 1997-11-20
ES2186888T3 (es) 2003-05-16
NO984836D0 (no) 1998-10-16
RU2179553C2 (ru) 2002-02-20
CZ334998A3 (cs) 1999-06-16
HK1018271A1 (en) 1999-12-17
ID17723A (id) 1998-01-22
EP0898566A1 (en) 1999-03-03
HU224637B1 (hu) 2005-12-28
WO1997040027A1 (en) 1997-10-30
NZ332334A (en) 2000-06-23
NO311976B1 (no) 2002-02-25
CA2251820A1 (en) 1997-10-30
IL120669A0 (en) 1997-08-14
TR199802104T2 (xx) 2000-09-21
NO984836L (no) 1998-12-16
EP0898566B1 (en) 2002-11-06
HUP9901434A3 (en) 2001-11-28
HUP9901434A2 (hu) 1999-08-30
CA2251820C (en) 2007-03-27
PT898566E (pt) 2003-03-31
AU725847B2 (en) 2000-10-19
CZ295747B6 (cs) 2005-10-12
DK0898566T3 (da) 2003-03-03
IL120669A (en) 2001-04-30
JP2000508672A (ja) 2000-07-11
BR9708790A (pt) 1999-08-03
AR006719A1 (es) 1999-09-08
TW498070B (en) 2002-08-11
ATE227278T1 (de) 2002-11-15
CN1219169A (zh) 1999-06-09
PL192561B1 (pl) 2006-11-30
PL329348A1 (en) 1999-03-29

Similar Documents

Publication Publication Date Title
CN1139580C (zh) 取代的苄胺及它们用于治疗抑郁症的用途
CN1036456C (zh) 氨基取代的吡唑
CN1304372C (zh) 可用作pdeiv抑制剂的三取代苯基衍生物
CN1832927A (zh) 新型γ－分泌酶抑制剂
CN1620438A (zh) 用作cbi拮抗剂的5,6－二芳基－吡嗪－2－酰胺衍生物
CN1522244A (zh) 邻氨基苯甲酰胺类化合物、其制备方法、其作为抗心律不齐剂的应用及其药物制剂
CN1218472A (zh) 药学上有用的化合物
CN1217711A (zh) 用作选择性多巴胺d3配体的芳基取代的环胺类化合物
CN1251569A (zh) 新颖化合物,其用途及制法
CN1788002A (zh) 作为钠通道阻滞剂的联芳基取代的三唑化合物
CN1117965A (zh) 取代的4-苯基-吡啶酮和4-苯基-2-烷氧基吡啶
CN1250544C (zh) 吡啶并芳基苯基噁唑烷酮抗菌剂和相关组合物及方法
CN1226825A (zh) 胺化合物用于制备阻止肿瘤细胞增殖的药物
CN1205704A (zh) 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物
CN1956954A (zh) 新的雄激素
CN1910177A (zh) 取代的喹啉及其作为分枝杆菌抑制剂的用途
CN1749256A (zh) 一类新的噁唑烷酮衍生物、其制备方法和用途
CN1187336C (zh) 咪唑类衍生物
CN1324018C (zh) 作为组织蛋白酶s抑制剂的寡肽以及含有它们的组合物
CN1882546A (zh) 用于治疗神经病疼痛的吡啶－4－基胺化合物
CN1271055C (zh) 作为非核苷反转录酶抑制剂的脲和硫脲的衍生物
CN1630515A (zh) 在糖皮质激素受体ii上有活性的化合物
KR100498823B1 (ko) 치환된벤질아민및이를우울증의치료에사용한방법
CN1180357A (zh) 5H,10H－咪唑并[1,2－a]茚并[1,2－e]吡嗪－4－酮衍生物、其制备和含有它们的药物
CN1188476A (zh) 4－苯氨基噻唑衍生物、其制备方法及其药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: ORGANON NV

Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP.

Effective date: 20070105

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20070105

Address after: Holland

Patentee after: N.V. ORGANON

Address before: Holland Arnhem

Patentee before: AKZO NOBEL N.V.

C56 Change in the name or address of the patentee

Owner name: MSD OS CO., LTD.

Free format text: FORMER NAME: ORGANON NV

CP01 Change in the name or title of a patent holder

Address after: Holland

Patentee after: N.V. Organon

Address before: Holland

Patentee before: N.V. ORGANON

ASS Succession or assignment of patent right

Owner name: ORGANON BIOLOGICAL NETHERLANDS CO., LTD.

Free format text: FORMER OWNER: MSD OUSI CO., LTD.

Effective date: 20131014

Owner name: MERCK SHARP + DOHME CORP.

Free format text: FORMER OWNER: ORGANON BIOLOGICAL NETHERLANDS CO., LTD.

Effective date: 20131014

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20131014

Address after: Haarlem

Patentee after: MERCK SHARP & DOHME B.V.

Address before: Haarlem

Patentee before: Organon biological science Holland Co.,Ltd.

Effective date of registration: 20131014

Address after: Haarlem

Patentee after: Organon biological science Holland Co.,Ltd.

Address before: Holland

Patentee before: N.V. Organon

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20040225